Rock Springs Capital Management LP Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$4.6B
Holdings
151
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (151 positions)
| Stock | Value |
|---|---|
AGIOAGIOS PHARMACEUTICALS INC | $131.4M |
HUMHUMANA INC | $126.2M |
ZLABZAI LAB LTD | $124.6M |
AVIRATEA PHARMACEUTICALS INC | $104.7M |
UNHUNITEDHEALTH GROUP INC | $102.3M |
—FIVE PRIME THERAPEUTICS INC | $100.2M |
NBIXNEUROCRINE BIOSCIENCES INC | $98.7M |
IMCRIMMUNOCORE HLDGS PLC | $97.6M |
PODDINSULET CORP | $96.8M |
AFWALIGN TECHNOLOGY INC | $96.1M |
ACRSACLARIS THERAPEUTICS INC | $89.9M |
ISRGINTUITIVE SURGICAL INC | $88.7M |
IDXXIDEXX LABS INC | $88.1M |
HCAHCA HEALTHCARE INC | $84.8M |
NVTA1EURINVITAE CORP | $84.6M |
NVV1NOVAVAX INC | $83.6M |
ARGXARGENX SE | $82.6M |
FRPTFRESHPET INC | $80.4M |
EXASEXACT SCIENCES CORP | $75.1M |
2L9BLUEPRINT MEDICINES CORP | $72.6M |
PCRXPACIRA BIOSCIENCES INC | $71.8M |
ONCBEIGENE LTD | $69.6M |
NVROEURNEVRO CORP | $67.7M |
IRTCIRHYTHM TECHNOLOGIES INC | $60.1M |
HZNPHORIZON THERAPEUTICS PUB L | $57.5M |
MRTXEURMIRATI THERAPEUTICS INC | $55.4M |
TFXTELEFLEX INCORPORATED | $54.0M |
BOLT1EURBOLT BIOTHERAPEUTICS INC | $51.3M |
RAREULTRAGENYX PHARMACEUTICAL IN | $51.2M |
EWEDWARDS LIFESCIENCES CORP | $48.7M |
—MERSANA THERAPEUTICS INC | $44.9M |
CGEMCULLINAN ONCOLOGY INC | $44.8M |
KRTXKARUNA THERAPEUTICS INC | $44.3M |
PHRPHREESIA INC | $44.3M |
—EARGO INC | $42.5M |
ALNYALNYLAM PHARMACEUTICALS INC | $42.4M |
CVETUSDCOVETRUS INC | $42.0M |
ARVNARVINAS INC | $41.1M |
EHCENCOMPASS HEALTH CORP | $41.0M |
ACHCACADIA HEALTHCARE COMPANY IN | $40.0M |
PENPENUMBRA INC | $39.9M |
TVTXTRAVERE THERAPEUTICS INC | $36.8M |
HCATHEALTH CATALYST INC | $36.7M |
ALLKGUSDALLAKOS INC | $35.1M |
SGENUSDSEAGEN INC | $34.7M |
ARDXARDELYX INC | $34.3M |
AZNASTRAZENECA PLC | $32.3M |
BIIBBIOGEN INC | $31.8M |
BSXBOSTON SCIENTIFIC CORP | $30.9M |
GHGUARDANT HEALTH INC | $30.5M |
MDGLMADRIGAL PHARMACEUTICALS INC | $30.2M |
ASNDASCENDIS PHARMA A/S | $30.1M |
MIRMMIRUM PHARMACEUTICALS INC | $29.8M |
EVHEVOLENT HEALTH INC | $29.2M |
PRTAPROTHENA CORP PLC | $29.1M |
SWAVUSDSHOCKWAVE MED INC | $28.7M |
ACCDEURACCOLADE INC | $28.4M |
ACADACADIA PHARMACEUTICALS INC | $27.8M |
LUNGPULMONX CORP | $27.1M |
SPRBSPRUCE BIOSCIENCES INC | $26.2M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $26.2M |
AMRNAMARIN CORP PLC | $26.1M |
—PPD INC | $25.5M |
SRPTSAREPTA THERAPEUTICS INC | $24.5M |
—EPIZYME INC | $24.4M |
KYMRKYMERA THERAPEUTICS INC | $24.2M |
NVCRNOVOCURE LTD | $23.1M |
—INTERSECT ENT INC | $22.6M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $21.8M |
INSPINSPIRE MED SYS INC | $20.7M |
—ABCAM PLC | $20.6M |
OSH3EUROAK STR HEALTH INC | $20.4M |
KURAKURA ONCOLOGY INC | $20.1M |
BMRNBIOMARIN PHARMACEUTICAL INC | $19.1M |
CYTK 4 11/15/26CYTOKINETICS INC | $19.1M |
RCKTROCKET PHARMACEUTICALS INC | $17.9M |
—SIERRA ONCOLOGY INC | $17.5M |
—GAMIDA CELL LTD | $17.0M |
INZYINOZYME PHARMA INC | $16.4M |
PRLDPRELUDE THERAPEUTICS INC | $16.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $16.3M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $16.2M |
NKTXNKARTA INC | $16.2M |
MREOMEREO BIOPHARMA GROUP PLC | $15.1M |
AKROAKERO THERAPEUTICS INC | $15.1M |
EPIEURESSA PHARMA INC | $14.6M |
—ATHIRA PHARMA INC | $14.5M |
—OLINK HLDG AB | $14.4M |
SPROSPERO THERAPEUTICS INC | $14.2M |
GOSS 5 06/01/27GOSSAMER BIO INC | $14.0M |
TBPHTHERAVANCE BIOPHARMA INC | $13.9M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $13.8M |
APLTAPPLIED THERAPEUTICS INC | $13.2M |
TGTXTG THERAPEUTICS INC | $12.8M |
RYTMRHYTHM PHARMACEUTICALS INC | $12.7M |
GLPGGALAPAGOS NV | $12.7M |
MGNXMACROGENICS INC | $12.5M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $12.5M |
INNVINNOVAGE HLDG CORP | $12.3M |
—PARATEK PHARMACEUTICALS INC | $11.9M |
Page 1 of 2Next